We are live on ! Find out more
JAZZ icon

Jazz Pharmaceuticals
JAZZ

486 hedge funds and large institutions have $8.82B invested in Jazz Pharmaceuticals in 2022 Q4 according to their latest regulatory filings, with 73 funds opening new positions, 183 increasing their positions, 138 reducing their positions, and 47 closing their positions.

New
Increased
Maintained
Reduced
Closed

55% more first-time investments, than exits

New positions opened: 73 | Existing positions closed: 47

33% more repeat investments, than reductions

Existing positions increased: 183 | Existing positions reduced: 138

14% more capital invested

Capital invested by funds: $7.76B → $8.82B (+$1.06B)

4% more funds holding

Funds holding: 468 → 486 (+18)

3.61% less ownership

Funds ownership: 92.87% → 89.26% (-3.6%)

11% less funds holding in top 10

Funds holding in top 10: 9 → 8 (-1)

51% less call options, than puts

Call options by funds: $28.3M | Put options by funds: $58.4M

Holders
486
Holders Change
+18
Holders Change %
+3.85%
% of All Funds
7.81%
Holding in Top 10
8
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-11.11%
% of All Funds
0.13%
New
73
Increased
183
Reduced
138
Closed
47
Calls
$28.3M
Puts
$58.4M
Net Calls
-$30M
Net Calls Change
-$59.6M

Top Buyers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
+$92.1M
2
APM
Avidity Partners Management
Texas
+$60M
3
Pacer Advisors
Pacer Advisors
Pennsylvania
+$49.5M
4
LSV Asset Management
LSV Asset Management
Illinois
+$43.2M
5
RG
Redmile Group
California
+$34.8M

Top Sellers

Rank Fund Capital Flow
1
Janus Henderson Group
Janus Henderson Group
United Kingdom
-$202M
2
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board
Ontario, Canada
-$96.7M
3
JP Morgan Chase
JP Morgan Chase
New York
-$96.6M
4
PHS
PFM Health Sciences
California
-$83.8M
5
SC
Samlyn Capital
New York
-$61.8M
Name Holding Trade Value Shares
Change 		Change in
Stake
CAL
451
Capital Advisors Ltd
Ohio
$2K +$1.61K +11 +1,100%
OLVIG
452
Oliver Lagore Vanvalin Investment Group
Michigan
$1.91K -$147 -1 -8%
BBPWM
453
Blue Bell Private Wealth Management
Pennsylvania
$1.91K – – –
CA
454
Clearstead Advisors
Ohio
$1.91K – – –
MAWCM
455
Mine & Arao Wealth Creation & Management
California
$1.91K – – –
AF
456
Advisornet Financial
Minnesota
$1.91K +$1.61K +11 +1,100%
WTC
457
WhitTier Trust Company
Nevada
$1.91K +$1.76K +12 New
DI
458
Disciplined Investments
Oklahoma
$1.75K +$440 +3 +38%
MSCM
459
McElhenny Sheffield Capital Management
Texas
$1.75K +$1.61K +11 New
FSWA
460
Financial Synergies Wealth Advisors
Texas
$1.59K +$586 +4 +67%
PFG
461
Piershale Financial Group
Illinois
$1.59K +$1.47K +10 New
RA
462
Rise Advisors
New York
$1.43K – – –
CA
463
CoreCap Advisors
Michigan
$1.43K +$1.32K +9 New
HWA
464
Heritage Wealth Advisors
Virginia
$1.27K – – –
CPG
465
Cornerstone Planning Group
New Jersey
$1.25K +$1.17K +8 New
FGAM
466
Financial Gravity Asset Management
Texas
$1.15K -$503K -3,432 -96%
GI
467
Gradient Investments
Minnesota
$1.11K – – –
HGERS
468
Householder Group Estate & Retirement Specialist
Arizona
$1K -$1.17K -8 -44%
CWM
469
CarsonAllaria Wealth Management
Illinois
$1K – – –
PTC
470
Private Trust Company
Ohio
$1K – – –
FMP
471
Financial Management Professionals
Texas
$1K +$586 +4 New
AIC
472
Archer Investment Corporation
Indiana
$956 – – –
Fidelity International
473
Fidelity International
Bermuda
$956 +$440 +3 +100%
AA
474
Addison Advisors
Vermont
$797 – – –
WT
475
Washington Trust
Rhode Island
$637 – – –
17 18
19
20 21

JAZZ Hedge Fund Activity: Q4 2022 in Review

486 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Jazz Pharmaceuticals (JAZZ) for Q4 2022, worth a combined $8.82B — up 14% from $7.76B a quarter earlier.

Buyers outnumbered sellers: 73 funds opened new JAZZ positions and 47 closed out — a net gain of 26 holders — while 183 added to existing stakes and 138 trimmed.

The largest buyer was Citadel Advisors, opening a new position worth an estimated $92.1M. The largest seller was Janus Henderson Group, cutting an estimated $202M.

  • 486 institutional investors held Jazz Pharmaceuticals (JAZZ) as of Q4 2022, up from 468 in Q3 2022.
  • Funds reported $8.82B of Jazz Pharmaceuticals stock for Q4 2022, up 14% quarter-over-quarter.
  • 73 funds opened new Jazz Pharmaceuticals positions in Q4 2022 and 47 closed out, a net change of +26 holders.
  • The largest Jazz Pharmaceuticals buyer in Q4 2022 was Citadel Advisors, an estimated $92.1M added.
  • The largest Jazz Pharmaceuticals seller in Q4 2022 was Janus Henderson Group, an estimated $202M sold.

Based on aggregated 13F filings for Q4 2022.